Introduction: Stroke is one of the leading causes of morbidity, disability, and mortality in high-income countries. Early prehospital stroke recognition plays a fundamental role, because most clinical decisions should be made within the first hours after onset of symptoms. The Cincinnati Prehospital Stroke Scale (CPSS) is a validated screening tool whose utilization is suggested during triage. The aim of this study is to review the role of the CPSS by assessing its sensitivity and specificity in prehospital and hospital settings. Methods: A systematic review and a meta-analysis of the literature reporting the CPSS sensitivity and specificity among patients suspected of stroke were undertaken. Electronic databases were searched up to December 2018, and the quality assessment was carried out by using the Revised Quality Assessment of Diagnostic Accuracy Studies −2 (QUADAS-2). Results: Eleven studies were included in the meta-analysis. Results showed an overall sensitivity of 82.46% (95% confidence interval [CI] 74.83-88.09%) and specificity of 56.95% (95% CI 41.78-70.92). No significant differences were found in terms of sensitivity when CPSS was performed by physicians (80.11%, 95% CI 66.14-89.25%) or non-physicians (81.11%, 95% CI 69.78-88.87%). However, administration by physicians resulted in higher specificity (73.57%, 95% CI 65.78-80.12%) when compared to administration by non-physicians (50.07%, 95% CI 31.54-68.58%). Prospective studies showed higher specificity 71.61% (95% CI 61.12-80.18%) and sensitivity 86.82% (95% CI 74.72-93.63) when compared to retrospective studies which showed specificity of 33.37% (95% CI 22.79-45.94%) and sensitivity of 78.52% (95% CI 75.08-81.60). Conclusions: The CPSS is a standardized and easy-to-use stroke screening tool whose implementation in emergency systems protocols, along with proper and consistent coordination with local, regional, and state agencies, medical authorities and local experts are suggested.
Introduction
Nowadays, stroke is the second leading global cause of death after heart disease, and the third leading cause of disability. In 2015, an estimated 6.3 million deaths occurred because of cerebrovascular disease: a total of 3 million people died because of ischemic stroke and 3.3 million because of hemorrhagic stroke. 1, 2 In high-income countries such as Europe, in the last decades, a decreasing trend in stroke mortality rate was reported; for instance, in Italy, from 1990 to 2016, the number of deaths decreased by 17% (from 60,000 to 50,000), and a remarkable decrease by approximately 45% resulted in Denmark from 1994 to 2011. [3] [4] [5] Despite this declining trend in mortality, stroke Furthermore in 2010, stroke ranked in the top 18 diseases that contributed to years lived with disability worldwide and, among them, it is the only one that significantly increased from 1990 to 2010. 6 A significant improvement in patient outcomes is reported by several studies that showed that shorter treatment times increase the chance of returning to good function (ie, being independent and having slight disability or less) when treated within 4.5 hrs from symptoms onset. [7] [8] [9] [10] For this reason, numerous efforts to aid clinicians and Emergency Medical Staff (EMS) to fastly identify this pathology, either in hospital and prehospital settings, were carried out, and several stroke prediction scales were elaborated. The Cincinnati Prehospital Stroke Scale (CPSS), the Face-Arm-Speech-Time (FAST), the FAST-ED, the Rapid Arterial Occlusion Evaluation Scale, the Los Angeles Prehospital Stroke Screen (LAPSS) are stroke impairment scales developed to quickly assess possible stroke in patients in the prehospital setting. [11] [12] [13] [14] [15] The NIHSS, the Recognition Of Stroke in the Emergency Room, 3-item Stroke Scale, the Cincinnati Prehospital Stroke Severity Scale (CPSSS or C-STAT), were designed for hospital use with the aim of detecting stroke and its severity. [16] [17] [18] [19] In 2013, Jauch et al, reported that the best door-tophysician time should be less than 10 mins, and door-tostroke unit admission time less than 3 hrs. Moreover, EMS are recommended to reach the target time of: less than 20 mins from hospital arrival to CT scan, and less than 60 mins door-to-needle time. 20 For this reason, emergency medical systems should activate a prehospital stroke prenotification, which is associated both with earlier door-to imaging time (25 mins reduction) and door-to-needle time (60 mins reduction). Currently, the CPSS, the FAST, and the LAPSS scales are recommended by the American Heart Association/American Stroke Association guidelines as validated and standardized tools for stroke screening, even if there is no strong evidence that suggests a higher accuracy of one over the other. 21, 22 The CPSS, proposed by Kothari et al (1999) , in particular, is a short, practical, and easy-to-use scale, developed extracting 3 of the 15 symptoms from the NIHSS, the gold standard for the assessment of stroke severity. 23, 24 The CPSS assesses facial palsy, asymmetric arm weakness, and speech disturbances, and each item can be scored as normal or not; if any of three is abnormal, the patient is suspected of having a stroke.
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In the last two decades, reviews were published with the aim of comparing existing scales, but none of them focused only on the validity of the CPSS in terms of sensitivity and specificity, even if it is one of the most commonly used prehospital tools, included in several stroke emergency medical systems protocols and national recommendations. [25] [26] [27] The aim of this study is to systematically review the role of the CPSS, globally assessing its sensitivity and specificity in prehospital and hospital settings.
Methods

Study design and literature search
A systematic review and meta-analysis of the scientific literature were conducted. Literature search was carried out querying the following electronic databases: EMBASE, PubMed, Web Of Science, Cochrane, and Scopus from their commencements to December 2018, without language restrictions. The search string was created using the elements of the PICO model (P, population/ patient; I, intervention/indicator; C, comparator/control; and O, outcome) and the Preferred Reporting Items for Systematic Reviews and Meta-Analyses check-list and flow diagram were used to collect and report data. 28, 29 The following search terms were used:
1. Terms related to Population: "brain ischemia", "carotid artery diseases", "intracranial embolism and thrombosis", "intracranial hemorrhages", "stroke", "acute cerebrovascular disease", "transient ischemic attack", "cerebrovascular accident", "cerebrovascular diseases", "cerebrovascular disorders", "brain vascular accident", "brain ischemia", "cerebrovascular occlusion"; 2. Terms linked to intervention: "Cincinnati Prehospital Stroke Scale"; 3. Terms related to measured outcomes: "sensitivity", "specificity", "positive predictive value", "negative predictive value", "reproducibility".
Boolean operators "OR" and "AND" were used to link the keywords.
References of individual studies were also backchecked for relevant studies, and hand search was used to identify missing articles. Two investigators independently screened titles and abstracts of all records to identify potentially relevant publications.
The following inclusion criteria were used: articles published in English, where the accuracy of the CPSS was assessed using as reference standard the hospital discharge diagnosis of stroke (ischemic, hemorrhagic, or transient ischemic attack).
Articles were excluded if they met at least one of the following criteria: pediatric population, studies without original data (reviews, editorials, practice guidelines, book reviews and chapters, meeting abstracts), quantitative analysis not reported.
Full texts of all potentially eligible studies that met the inclusion criteria were obtained and assessed in duplicate. At all levels, disagreements were resolved by discussion, and by involving a third reviewer when consensus could not be reached.
Quality assessment
Two independent researchers evaluated the validity of the selected studies using the Revised Quality Assessment of Diagnostic Accuracy Studies −2 (QUADAS-2) tool, a specific validated tool for the quality assessment of diagnostic accuracy studies. 30 The QUADAS-2 rates the risk of bias in four domains: The applicability form that follows the first three domains evaluates the correspondence between the study design and the purpose of the specific review to be carried out.
If at least one of the answer in each domain or in the concern regarding applicability was deemed at "high risk of bias", the final risk of bias of the relative domain or in the relative applicability item figures as "High". If the article did not provide sufficient information, the risk of bias figures as "Unclear". Otherwise, if no question found any risk of bias, the domain or the applicability form is scored as "low risk of bias".
Two investigators independently tested the tool for a small number of articles and, once validated, it was used to assess the quality of the included studies.
Data extraction and data analysis
From each study, data were manually extracted by two authors using a standardized form including the following information: first author's last name, year of publication, country, study design, setting, training in stroke scale of hospital and prehospital staff, administrator of the CPSS, population characteristics, type of stroke evaluated and if CPSS was derived from other source or directly performed. An overall estimation of sensitivity and specificity was achieved using a diagnostic test accuracy meta-analysis of the studies that included data on true positives (TP), true negatives (TN), false positives (FP), and false negatives (FN); when these latter not directly reported, they were derived from available data of the included studies.
Pooled and stratified sensitivity and specificity of CPSS (95% confidence interval) and summary receiver operating characteristic (sROC) curves were obtained using STATA 13.0 and Cochrane RevMan 5.3. 31, 32 Stratified analyses were performed according to the study design, setting, scale administrator, and type of stroke investigated. Diagnostic odds ratio (DOR), pooled positive and negative likelihood ratios (LR+ and LR-), were obtained to assess the informative power of the tests.
Results
Study selection
From a total of 448 articles, 386 were excluded after duplicates removal, and title and abstract reading. The remaining 62 articles were selected for full-text review, 44 were excluded because they did not meet the inclusion criteria of this study. A flow diagram describing the article selection process is shown in Figure 1 . A total of 18 articles were qualitatively synthesized, and eventually 11 were included in the meta-analysis.
Study and population characteristics
The included studies were conducted in the following countries: United States, [33] [34] [35] [36] [37] [38] [39] [40] [41] Australia, 42, 43 Italy, 44 United
Kingdom, 17 Germany, 45, 46 India, 47 China, 48 and Belgium. 49 All studies were observational, 6 analyzed a retrospective registry 33 Almost all studies (72.22%) investigated all types of stroke (Ischemic, hemorrhagic, and transient ischemic attack); while five studies 36, 38, 40, 44, 45 focused on a particular type of stroke.
The population sizes ranged from 31 to 1,217, for a total amount of 6,954 subjects enrolled. Mean age ranged from 57.8 to 77 years. Male proportion ranged from 6.93% to 67.59%. Four studies (22.22%) conducted in the US also reported the ethnicity of the population. 35, 37, 40, 41 In Table 1 
Quality assessment
The overall methodological quality of all included studies (n=18) is summarized in Table 2 and Figure 2 .
No study was deemed at low risk for bias in all the domains, with the exception of one study. 48 In the first domain that regards the patient selection domain, seven studies 33,36-38,44,45,49 scored a high risk of bias (sample of patients enrolled in a non-consecutive, nonrandom way or inappropriate exclusions not avoided). In the second domain, index test, only one study 36 had a high risk of bias, because the CPSS threshold was defined after analysis, and one 33 scored unclear risk of bias because investigators stated that they did not know whether all of the emergency medical system agencies considered the CPSS as positive when only one of the three symptoms was detected. As to the domain 3, reference standard, five articles reported the blind assessment of the reference standard without knowledge of CPSS results, 37, 40, 44, 45, 48 otherwise, the other studies were reported as having unclear risk of bias because details about the blind assessment were not reported. Only one study 33 had an unclear risk of bias in the applicability item: for what concerns the selection of patients, it was not known whether stroke was the reason for transport by EMS or a comorbidity; as to the index test, it is not clear if its interpretation was positive when at least one item was scored as abnormal. Seven studies showed high risks of bias regarding the applicability: five of them included only some types of stroke; 36, 38, 40, 44, 45 two enrolled admitted patients; 17, 37 and with regard to the index test, in one study 37 physicians performed the CPSS but the EMS gave the final score, while in another study 17 the CPSS results were derived from the neurological exam not performed in emergency setting. 
CPSS accuracy
The CPSS TP, TN, FP, and FN, for each study that was included in the meta-analysis, along with their sensitivity and sensibility (95% confidence intervals), and the forest plot are reported in Figure 3 . Among the 11 studies included, the pooled sensitivity and specificity were 82.46% (95% CI 74.93-88.09%) and 56.95 (95% CI 41.78-70.92%), respectively, and the sROC is shown Figure 4 . The overall DOR was 6.22, the positive likelihood ratio (LR+) and the negative likelihood ratio (LR-) were 1.92 and 0.31, respectively.
Data were stratified according to the administrator of the CPSS: physicians or non-physicians.
As for the former, pooled sensitivity was 80.11% (95% CI 66.14-89.25%), and pooled specificity was 73.57% (95% CI 65.78-80.12%). In the latter, pooled sensitivity was 81.11% (95% CI 69.78-88.87%), pooled specificity was 50.07% (95% CI 31.54-68.58%). DOR was 11.21 and 4.30 among physicians and non-physicians, respectively; pooled LR+ and LRwere 3.03 and 0.27 for physicians and 1.62 and 0.38 for nonphysicians, respectively.
Data regarding CPSS accuracy were also stratified according to the study design: pooled sensitivity and specificity among retrospective studies was 78.52% (95% CI 75.08-81.60%) and 33 Data were not sufficient to stratify and assess differences among settings and types of stroke.
Seven studies were not included in meta-analyses. Five studies were not included in the meta-analysis because CPSS TP, TN, FP, FN were not classified in the same way across studies, therefore were not comparable to the classification carried out by the others. 36, 38, 40, 44, 45 The first 38 excluded hemorrhagic stroke, and did not assess specificity (sensitivity 84.7%); the second study 45 vascular territories (sensitivity 94%; specificity 29%); the fourth 40 included only those with large vessel occlusion (Sensitivity 75%; specificity 41%); eventually, the fifth 44 assigned TIA patients to non-stroke group, considering them among TN (sensitivity 75%; specificity 78%). Two studies 39, 47 were not included because they did not provide sufficient information about TP, TN, FP, FN. Maddali et al 47 included 66 individuals in the study and found that the sensitivity and specificity reached 81.4% (95% CI 68.5-90.7%) and 100% (95% CI 29.2-100%), respectively. Furthermore, data were not reported with regard to the CPSS setting of administration (prehospital or hospital setting) and were not stratified according to the type of administrator. Eventually, a study 39 reported data only regarding the sensitivity (44%, 95% CI 39-49%) but did not assess the specificity.
Discussion
The results of this systematic review show that the CPSS can be helpful in detecting stroke, with an overall sensitivity of 82.46% and specificity of 56.95%. These results are consistent with those of previous systematic reviews and meta-analysis aimed at comparing sensitivity and specificity of other scales. [50] [51] [52] In fact, the CPSS has shown similar outcomes in terms of sensitivity and specificity when compared to other scales that are also recommended in prehospital setting, 21 such as the FAST scale, which investigates the same areas of the CPSS but without detailed questions to be addressed; and the LAPSS, which assesses motor asymmetries along with blood glucose level and anamnestic features. In contrast to the CPSS, the FAST scale evaluates the speech item by using the entire conversation with the individual suspected of stroke, without using a specific sentence to be repeated; for this reason the CPSS might have the advantage to be more reproducible and more standardized among providers; 46 the LAPSS takes about 5 mins to be performed, while the CPSS requires about 1.5 mins. 53, 54 However, it should be considered that a positive CPSS does not necessarily result in a stroke diagnosis. This may be appreciated by looking at LR+ and LR-, which provide an idea of the test utility. As a matter of fact, LR+ has a small value in every examined scenario, so an abnormal CPSS result is more frequent in stroke patients than in healthy ones but not significantly. On the other hand, the likelihood ratio for a negative result (LR-) showed good values (0.27 and 0.18) in the two best scenarios (when performed by physicians and in prospective studies, respectively). 55 This means that CPSS can be considered a good triage tool when performed in the best way because the odds of having a stroke considerably decrease when the test is negative. Some sources of heterogeneity were investigated with regard to CPSS accuracy, others were hypothesized, but data were not available for assessing, for instance, differences among types of stroke or among settings. Most studies (77.78%) did not report the eligibility criteria for which the scale had to be administered to the study population. This might lead to an increase in heterogeneity and reduction in terms of the comparability among the study populations. Prospective studies showed a higher accuracy above all in terms of specificity (increase of specificity of almost 40%, from 33.37% in retrospective studies to 71.60% in prospective ones) and of sensitivity (increase of sensitivity of 8%, from 78.52% to 86.82%). A recent systematic review, that analyzed several prehospital scales (not including CPSS), reported that looking at the forest plot distribution according to study design stroke screening scales performed better in retrospective studies when compared to prospective ones, and this may be due to a "difficult application of some scales in a real 'on-air' situation". 56 In this review, that focuses on the CPSS, a better accuracy in prospective studies was found, probably because the previous review 56 analyzed more complex prehospital scales. In fact, the CPSS is a very simple scale, easily applicable in the emergency medical system. For this reason, when planning to start a prospective study on the CPSS, an educational intervention that underlines the importance both of a correct administration of the tool and data collection, might be more effective. Another source of heterogeneity was identified among the administrators of the CPSS. When physicians and non-physicians were compared sensitivity showed similar results (80.11% for the former and 81.11% for the latter group), while specificity increased by 46.94%, from 50.07% -among non-physicians -to 73.57% -among physicians. This might be due to the level of expertise achieved with education and training in the detection of signs of stroke during the performance of the CPSS; eg, one of the most recurrent mistakes while assessing the CPSS items is to simply ask patients to "smile" rather than "smile, showing your teeth", 52 weakening the accuracy of this scale.
For this reason, the educational component may need further evaluation, and it is suggested that for future studies the educational intervention they implemented should be reported.
A multilevel educational stroke program could be planned in order to reduce misclassification errors (FN or FP), also with the aim of lowering overtriage and undertriage. The CPSS, as a triage test, should help to maximize the number of patients with suspected stroke who need access to hospitals as soon as possible, because more subsequent test is performed to exclude FP. 57, 58 Since a low specificity parallels overtriage, it is suggested to locally calculate a threshold to define an overtriage as acceptable or not, because it depends on the capacity of the system to treat patients with suspected stroke in addition to the baseline caseload. 59, 60 Results from this review take into account the outcome that CPSS achieves in predicting stroke without distinguishing between ischemic, hemorrhagic stroke, and TIA. This could be important from the organizational perspective since all of the three pathologies share the same destination, ie, an advanced care center. It has been proven, in fact, that hemorrhagic strokes need a specialized evaluation to undergo supportive care or neurosurgery, and TIAs need monitoring because of the added risk of ischemic stroke, hospitalization for cardiovascular events, and death. 2, 61 Strengths and limitations of the study
The strengths of this review include a robust systematic process for search strategy, appraisal, data extraction, and description, supplemented with hand searching and forward citation searching. All screening and data extraction processes were performed by two independent reviewers. A limitation concerns the overall low quality of most of the included studies; however, as previously reported the risk of bias when examining diagnostic tools is generally high. 62, 63 A strength lies in the fact that CPSS is evaluated in real-world conditions, indirectly providing important information on its repeatability, reproducibility (standardized instruction to detect the signs), and ease of use. 64 Further research is needed to cover a wider perspective that takes into account the evaluation of a system by also addressing the additional value of patient safety, the ethical and socio-cultural implications, the organizational impact, and a cost-effectiveness analysis of the CPSS. This may help to understand and to quantify the global impact that might be brought by the introduction of this scale.
Conclusion
In conclusion, this research helps to explain and give an updated vision of the value of the CPSS as a screening tool that is aimed at supporting the diagnosis of stroke. It showed to be a simple, reproducible, easy to teach and to use the tool. For this reason, the implementation of emergency systems protocols, especially in hospital triage, that take into account the use of validated and standardized instrument for stroke screening as the CPSS, along with a proper and consistent evaluation and coordination among local, regional, state agencies, medical authorities and local experts, should be undertaken.
